13034 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Reg. FD
Announces Definitive Agreement to Be Acquired by Patient Square Capital in Transaction Valued at $2.6 Billion
Reports Fiscal-Year 2025 Fourth-Quarter and Full-Year Financial Results
Stewardship Outreach July 2025
Reports Fiscal-Year 2025 Third-Quarter Financial Results
Material Contracts, Reg. FD
Reports Fiscal-Year 2025 Second-Quarter Results
To Participate in J.P. Morgan Healthcare Conference on January 14, 2025
Q1
Amended Annual Report
FY 2024
Q3
Q2
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(4)
Prospectus filed pursuant to Rule 424(b)(3)
Additional Proxy Materials
Definitive Merger Proxy Statement
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Notice of Proposed Sale of Securities
PREM14A
Submission Upload
Correspondence